Global Alzheimer Diagnostic Testing Devices Pipeline Report 2020 - Stage of Development, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.
"Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020". Alzheimer Diagnostic Tests are test that detects the disease before it causes the symptoms. It measures key proteins or protein patterns in blood or spinal fluid (biomarkers).
Scope
Extensive coverage of the Alzheimer Diagnostic Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Alzheimer Overview
3 Products under Development
3.1 Alzheimer - Pipeline Products by Stage of Development
3.2 Alzheimer - Pipeline Products by Territory
3.3 Alzheimer - Pipeline Products by Regulatory Path
3.4 Alzheimer - Pipeline Products by Estimated Approval Date
3.5 Alzheimer - Ongoing Clinical Trials
4 Alzheimer - Pipeline Products under Development by Companies
4.1 Alzheimer Companies - Pipeline Products by Stage of Development
4.2 Alzheimer - Pipeline Products by Stage of Development
5 Alzheimer Companies and Product Overview
6 Alzheimer- Recent Developments
7. Appendix
Companies Mentioned
AC Immune SA
Acobiom
Acumen Pharmaceuticals Inc
Adlyfe Inc
Admit Therapeutics SL
ADx NeuroSciences NV
Aelan Cell Technologies
Agent Biotech
Albert Ludwigs University of Freiburg
Alere Inc
Alzhyme Pty Ltd
Alzinova AB
Amarantus Bioscience Holdings Inc
Amarantus Diagnostics Inc
Ambergen Inc
Amco International Manufacturing Inc.
Amoneta Diagnostics SAS
Amprion Inc
Applied NeuroSolutions, Inc. (Inactive)
Arkley Biotek LLC
attyloid GmbH
Banyan Biomarkers Inc
BioArctic AB
Bioasis Technologies Inc
Biocross SL
Biomedical Development Corp
BioSystems International
Boston University Medical Campus
Brigham and Women's Hospital
C2N Diagnostics LLC
Calviri Inc
Cassava Sciences Inc
Chronix Biomedical Inc
Cleveland Diagnostics Inc.
Cofactor Genomics Inc
Cognext Diagnostics LLC
Columbia University
CompanDX Ltd
Cymedx
Cytox Ltd
Diadem SRL
DiamiR LLC
DiaPat GmbH
Durin Technologies, Inc.
Emory University
Eurobio Scientific SA
Florida Institute of Technology
French National Institute of Health and Medical Research
Fujirebio Diagnostics Inc
Fujirebio Europe NV
GenoScreen SAS
Ghent University
IBM Research-Australia
ICDD-sas
Inbiomed
Innosense LLC
Innovative Health Diagnostics
Instituto de Estructura de la Materia
Integrated Diagnostics Inc (Inactive)
Janssen Pharmaceutica NV
Johns Hopkins University
Johns Hopkins University School of Medicine
KineMed Inc
King's College London
Lund University
McGill University Health Center
Medifron DBT Inc
Memory Dx LLC
Meso Scale Diagnostics LLC
Michigan State University
Myriad RBM Inc
NanoSomiX, Inc.
Nanosphere Inc
National University of Singapore
Nel ASA
NeoNeuro SAS
Neuro Bio Ltd
NeuroDiagnostics LLC
NeuroQuest Ltd
Neurotrope Bioscience Inc
Newcastle University
Novel Bio-spectrum Technologies Inc (Inactive)
Oligomerix inc
Orasi Medical, Inc. (Inactive)
Oryzon Genomics SA
Peri Rx Inc
Pre Diagnostics AS
Predemtec GmbH
ProMIS Neurosciences Inc
Proplex Technologies Llc
Protagen AG
Proteome Sciences Plc
Proteomics International Laboratories Ltd
Quanterix Corp
Redox Diagnostics LLC
Roche Diagnostics GmbH
Roche Diagnostics International Ltd
Ruhr-University Bochum
Scout Diagnostics LLC
Seer Biosciences Inc
Siemens Healthineers AG
StageZero Life Sciences Ltd
TauRx Pharmaceuticals Ltd
The Florey Institute of Neuroscience and Mental Health
The University of Nottingham
TopoGEN Inc
Trinity College Dublin
True Diagnostics Inc
University of Calgary
University of California San Diego
University of California San Francisco
University of Chicago
University of Georgia
University of Gottingen
University of Illinois at Chicago
University of Luxembourg
University of Maryland Baltimore
University of Melbourne
University of Oxford
University of Pittsburgh
University of South Florida
University of Texas Health Science Center at Houston
University of Texas Southwestern Medical Center
Urvogelbio Pvt Ltd
US Biomarkers Inc
vall d hebron institut de Recerca
Veravas Inc
Vitruvian Biomedical Inc
Washington University in St Louis
Washington University School of Medicine
Zoiray Technologies Inc.
For more information about this report visit https://www.researchandmarkets.com/r/hk82ld
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900